Interaction of retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthma

V. Pulkkinen, N. Acevedo, C. Söderhäll, E. Melen, C. Orsmark-Pietras, S. Ezer, J. Mandelin, M. van Hage, A. Scheyenius, G. Pershage, J. Kere (Helsinki, Finland; Stockholm, Huddinge, Sweden)

Source: Annual Congress 2012 - Asthma and the genes: from GWAS to next generation transcriptome analyses
Session: Asthma and the genes: from GWAS to next generation transcriptome analyses
Session type: Oral Presentation
Number: 1865
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Pulkkinen, N. Acevedo, C. Söderhäll, E. Melen, C. Orsmark-Pietras, S. Ezer, J. Mandelin, M. van Hage, A. Scheyenius, G. Pershage, J. Kere (Helsinki, Finland; Stockholm, Huddinge, Sweden). Interaction of retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthma. Eur Respir J 2012; 40: Suppl. 56, 1865

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IL33 receptor activation is IL33 isoform and receptor genotype specific
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019

The interaction of glucocorticoid and peroxisome proliferator-activated receptor γ agonist in asthmatic mice
Source: Eur Respir J 2006; 28: Suppl. 50, 226s
Year: 2006

The effect of leukotrienes and their receptor antagonists on calcium signalling in the cough receptors transient receptor potential ankyrin 1 (TRPA1) and vanilloid 1 (TRPV1)
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


Effect of rifampin, a potent organic-anion-transporting polypeptide inhibitor (OATPi), on the PK of BMS-986278, a lysophosphatidic acid receptor (LPA1) antagonist
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020


Association of adrenal response in asthmatic children on inhaled steroids with polymorphisms in the genes of glucocorticoid receptor (GR) and corticotropin releasing hormone receptor 1 (CRHR1)
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009


Role of peroxisome proliferator activated receptor γ in COPD
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009

Protease-activated receptor 2 (PAR2) stimulation potentiates citric acid induced cough by sensitising the vanilloid receptor-1 (TRPV1)
Source: Annual Congress 2003 - Novel drugs under development for the treatment of respiratory diseases
Year: 2003


Polymorphism in C-C Chemokine Receptor 5 (CCR5) increases susceptibility to Löfgren’s syndrome and alters receptor expression as well as functional response.
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021



The relationship of peroxisome proliferator activated receptor γ ligands and IL-6 in sepsis of rats
Source: Annual Congress 2009 - Acute lung injury and biomarkers
Year: 2009

Peroxisome proliferator activated receptor gamma (PPARγ) agonist rosiglitizone inhibits upregulation of mucin gene expression in two airway epithelial cell lines
Source: Eur Respir J 2005; 26: Suppl. 49, 97s
Year: 2005

Expression of glucocorticoid receptor beta (GCRβ) in asthmatic children and its correlation with clinical severity
Source: Eur Respir J 2004; 24: Suppl. 48, 162s
Year: 2004

Nicotinic alpha-7 receptor stimulation (a7nAChR) inhibited NF-kB/STAT3/SOCS3 pathways in a murine model of asthma.
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017



The role of peroxisome proliferator-activated receptor γ in pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009

Homozygosity for the FCER2 gene is associated with an increased use of leukotriene receptor antagonists
Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology
Year: 2017


PKA/cAMP-independent transactivation of glucocorticoid receptor by long acting β2 agonists
Source: Eur Respir J 2006; 28: Suppl. 50, 103s
Year: 2006

Mas receptor antagonist inhibits the pro-resolutive effects of Angiotensin-(1-7) in an experimental model of asthma.
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

No associations of the mineralocorticoid and glucocorticoid receptor genes with asthma
Source: Eur Respir J 2012; 40: 1572-1574
Year: 2012


Ligand independent activation of the glucocorticoid receptor by long acting β2 agonists
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004

Peroxisome proliferator-activated receptor gamma (PPARγ) protects against pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2007; 30: Suppl. 51, 6s
Year: 2007